SLIT2 and lung cancer: This work aims at the in silico prioritisation, and pathogenicity assessment of the missense variants of SLIT2/ROBO1/4 reported in lung cancer cases, based on sequence- and structure-based parameters followed by docking analyses to determine the interaction dynamics.